BNN is proud to announce its active involvement in two research services funded by the Austrian Ministry for Climate Action, Environment, Energy, Mobility, Innovation, and Technology (BMK), processed through the Austrian Research Promotion Agency (FFG). Both initiatives focus on advancing the Safe-and-Sustainable-by-Design (SSbD) framework, emphasizing the integration of socioeconomic aspects into sustainable innovation and have been kicked off in November.
PHASE5 addresses social considerations within the pharmaceutical industry. By partnering with the University of Graz and the Research Center Pharmaceutical Engineering GmbH (RCPE), this project aims to explore how social impacts can be embedded into the early stages of pharmaceutical product design according to SSbD. Together, the consortium will assess the status quo, identify hotspots and develop methods that enable the pharmaceutical sector to adopt socially responsible innovations.
SESAM evaluates the social and economic impact of applying the SSbD framework in early stages of innovation. BNN is collaborating with JOANNEUM RESEARCH, Brimatech, Phornano and TU Wien to assess the practical application of SSbD principles with a particular focus on sLCA. As part of the interdisciplinary effort, the SESAM team will create a simplified framework for measuring social and economic impact that will help companies align their innovation strategies with broader societal goals.
Through these two initiatives, BNN and BioNanoNet Association members continue to demonstrate their leading efforts in SSbD research and innovation, fostering collaborations that bridge science, industry, and society.
Contact
Clemens Wolf
clemens.wolf@bnn.at
This work has received funding from the Federal Ministry of the Republic of Austria for Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK) through the Austrian Research Promotion Agency (FFG) (PHASE5 and SESAM, NanoEHS 2023 national).